Skip to main content

Department of Cell and Tissue Culture

Department of Cell and Tissue Culture

The Department of Cell and Tissue Culture is one of the core divisions of the Libyan Biotechnology Research Center. It focuses on studying the structural and functional alteration that occur in human and animal cells and tissues as a result of exposure to chemical or natural substances, with the aim of evaluating their biological efficacy and toxicity. The department provides an advanced research environment that serves as an experimental platform for potential clinical or pre-clinical applications in humans and animals.
Research Areas:
1. Cancer Research: Evaluation of the effects of bioactive compounds extracted from local medicinal plants on cancer cell lines in vitro.
2. Toxicity Testing: Assessment of the potential toxic effects of various substances on tissue integrity and cellular health.
3. Cell and Immunology Research: Investigation of cell viability, cellular interactions with their microenvironment, and studies related to immune system function.
4. Immunohistochemical Detection of Cancer: Immunochemical analysis of tissues to identify tumor markers and cancer related biomarkers.

Research Projects

Hematologic Malignancies and Immune Monitoring Using Flow Cytometry

This project employs advanced flow cytometry technologies to investigate hematologic malignancies and assess immune responses in cancer patients. An advanced DEXI Flex flow cytometer (Beckman Coulter) equipped with 13 fluorescence filters is used for high-precision analysis of cellular characteristics and biomarkers. In addition, a BD Accuri flow cytometer with a 4- fluorescence filters is utilized for teaching and training purposes, supporting capacity building in flow cytometry applications.

Research Objectives:

  • Hematologic Malignancies:
  • Analysis of cellular and immunophenotypic profiles in:
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Myeloid Leukemia (CML)
  • Investigation of immune status by monitoring CD4⁺ and CD8⁺ T-cell populations Assessment performed
  • pre- and post-chemotherapy to evaluate treatment-related immune alterations.

Safe and Sterile Amniotic Membrane for the Treatment of Diabetic Foot Ulcers, Severe Burns, and Other Medical Applications

This project aims to prepare human amniotic membrane and utilize it as a biological dressing for the treatment of burns, chronic wounds, diabetic foot ulcers, and selected ocular disorders. The project focuses on evaluating the effects of different processing conditions on the amniotic membrane, including pre- and post-dehydration states and exposure to gamma irradiation at varying doses.

Special emphasis is placed on assessing structural integrity, cellular viability, and functional properties of the membrane following processing, in order to determine optimal conditions for safe clinical application.

The amniotic membrane is distinguished by its rich content of

  • Stem cells and progenitor cells
  • Epithelial and stromal tissue cells
  • Bioactive and nourishing compounds with low immunogenicity

Project Objectives

  • To prepare the amniotic membrane using sterile, safe, and standardized processing methods.
  • To produce amniotic membrane based biological dressings that promote accelerated wound healing and tissue regeneration.